Back to search

Cornell University

Enhancing the Efficacy of Peptide-based Degraders against Estrogen Receptor α using Ionizable Lipid Nanoparticles

Abstract

dc:description.abstract

Proteolysis targeting chimeras (PROTACs) are heterobifunctional molecules that recruit endogenous E3-ubiquitin ligases to catalytically degrade target proteins. Peptide-based PROTACs (PepTACs) extend this strategy by harnessing peptides to selectively engage traditionally “undruggable” protein targets—including mutated or post-translationally modified isoforms that are often inaccessible to small-molecule ligands. Despite their promise, PepTACs face major translational challenges due to their poor cellular internalization and rapid proteolytic degradation. Recent work from our group demonstrated that encapsulating PepTACs in ionizable lipid nanoparticles (iLNPs) markedly enhances their intracellular delivery and degradation potency against CREPT and β-catenin, oncotargets implicated in metastatic cancers driven by aberrant Wnt signaling. Building on this success, the current study investigates whether iLNP-based delivery can be repurposed to improve the efficacy of PepTACs against Estrogen Receptor α (ERα)—a mutationally plastic nuclear transcription factor critically implicated in resistance-prone, metastatic breast cancer.We found that enhancing the anionic character of the PepTAC—via poly-glutamate tagging in the PepTAC sequence and pH-tuned iLNP formulation—significantly improves PepTAC encapsulation and its corresponding intracellular uptake. Preliminary results further revealed that systematically optimized iLNP formulations enabled previously unobserved ERα degradation by a linear, anionically tagged PepTAC with a substantially improved potency. These findings inform that continued refinement of PepTAC’s sequence-dependent physicochemical properties with the iLNP formulation parameters lead to an enhanced target knockdown efficacy of PepTACs that can be translated in vivo for appropriate disease models. The overarching goal is to establish a generalizable iLNP–PepTAC platform for efficiently targeting mutationally adaptive, treatment-refractory oncoproteins with diverse peptide-based degraders—thereby expanding the reach and precision of targeted protein degradation into intracellular proteomes previously inaccessible to small-molecule therapeutics.

Degree

thesis:*
Name thesis:degree_name
M.S., Chemical Engineering
Level thesis:degree_level
Master of Science
Discipline thesis:degree_discipline
Chemical Engineering
Grantor
Cornell University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Srivastava, Shreeya
Chair dc:contributor.chair
  • Alabi, Christopher
Committee member dc:contributor.committeemember
  • Putnam, David

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
17422643
Dc Identifier Other
ProQuest Submission ID: 12553
ProQuest Publication ID: 32170627

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Srivastava, Shreeya. Enhancing the Efficacy of Peptide-based Degraders against Estrogen Receptor α using Ionizable Lipid Nanoparticles. Master of Science thesis, Cornell University, 2025. https://hdl.handle.net/1813/120666